Skip to content
Samsrita Labs logo

Samsrita Labs

539267 BSE
Price unavailable

Samsrita Labs (SAMSRITA) share price was ₹12.00 at the 28 Oct 2026 close; market capitalisation ₹27.28 Cr; sector Healthcare Services. The share price fell 41.9% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Jun 2026 quarter, revenue was under ₹1 Cr and net profit was −₹0.19 Cr. Promoters held 25.44% of Samsrita Labs in Sep 2026, unchanged from Jun 2026. Its Tapetide Score is 33/100 (Poor) as of 28 Oct 2026.

Close 28 Oct 2026 ₹12.00 −8.92 −42.64% 1Y

Key Fundamentals

MicrocapHealthcare ServicesHealthcare
Market Cap
₹27.28 Cr
EBITDA
−₹8.70 Cr
Return on Equity
-73.9%
Debt to Equity
0.14
Book Value
₹5.17
EPS (TTM)
−₹3.58
52W High
₹25.27
52W Low
₹10.15

Price-based figures as of 28 Oct 2026, 15:30 IST · EPS basis: Consolidated · TTM

Peer Comparison

Healthcare › Healthcare Services › Healthcare Service Provider

Dr Lal Pathlabs
₹1,905.4058.9231,982 Cr12.750.26%20.06%25.67%2,996 Cr545 Cr
Vijaya Diagnostic Centre
₹1,438.9078.9314,820 Cr15.480.14%18.07%19.22%879 Cr187 Cr
Metropolis Healthcare
₹549.1056.4311,388 Cr7.580.91%12.54%15.73%1,733 Cr203 Cr
Thyrocare Technologies
₹514.6546.458,191 Cr15.982.84%27.79%33.84%894 Cr176 Cr
Nephrocare Health Services
₹630.30150.436,338 Cr5.680.00%6.88%13.46%1,079 Cr85 Cr
Suraksha Diagnostic
₹318.3546.271,658 Cr6.770.16%12.90%14.70%329 Cr35 Cr
Krsnaa Diagnostics
₹496.0516.271,609 Cr1.640.40%10.35%10.64%862 Cr98 Cr
Samsrita Labs (this company)
——27 Cr2.320.00%-73.90%-73.32%0 Cr-8 Cr
Median 8 companies₹549.1056.437,265 Cr7.180.21%12.72%15.22%887 Cr137 Cr

Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.

Tapetide Score

Data-driven rating, 0–100, as of . How it works →

33 Poor
Overall score

Data confidence 75/100

Category scores

Quality Poor 13
Returns, margins, earnings quality 24% weight
Valuation Weak 39
Cheap vs sector & own history 26% weight
Financial Health Weak 44
Solvency, leverage, coverage 10% weight
Momentum Poor 19
Trend strength, vol-adjusted 13% weight
Ownership Average 50
FII/DII/promoter flows 26% weight

The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.

Key Insights

Strengths

1
  • Company has reduced debt.

Weaknesses

5
  • Company has low interest coverage ratio.
  • Promoter holding is low: 25.4%
  • Company has a low return on equity of -23.9% over last 3 years.
  • Company has high debtors of 365 days.
  • Promoter holding has decreased over last 3 years: -27.4%

Technical Indicators

Oscillators

Bullish

Bearish
0
Neutral
7
Bullish
2

Overall

Bearish

Bearish
7
Neutral
7
Bullish
5

Moving Averages

Bearish

Bearish
7
Neutral
0
Bullish
3

Growth Rate

Revenue Growth
-100%

vs previous quarter

Net Income Growth
—

Cash Flow Change
—

EBITDA Margin Change
-200%

vs previous quarter

Quarterly Results

Particulars Dec 2019Mar 2020Jun 2020Sep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2024Sep 2025Dec 2025Mar 2026Jun 2026
Sales
0.42
0.24
0.01
0
0
0
0
0
0
0
0
0.02
0
Expenses
0.89
0.76
0.32
0.35
0.23
0.07
0.08
0.06
0
4.93
3.36
0.17
0.31
Operating Profit
-0.47
-0.52
-0.31
-0.35
-0.23
-0.07
-0.08
-0.06
0
-4.93
-3.36
-0.15
-0.31
OPM %
-111.9%
-216.67%
-3100%
—
—
—
—
—
—
—
—
-750%
—
Other Income
0.05
0.05
0.04
0.04
0.04
0.04
0.04
0.04
0
0
0
0.03
0
Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0.01
0
0
0
0
0
0
0
0
0
0
0
PBT
-0.42
-0.48
-0.27
-0.31
-0.19
-0.03
-0.04
-0.02
0
-4.93
-3.36
-0.12
-0.31
Tax %
0%
-14.58%
0%
-3.23%
0%
-66.67%
0%
0%
—
0%
0%
0%
0%
Net Profit
-0.42
-0.41
-0.27
-0.3
-0.19
-0.01
-0.04
-0.02
0
-4.55
-2.94
-0.48
-0.19
EPS (₹)
-0.28
-0.28
-0.18
-0.2
-0.13
-0.01
-0.03
-0.01
0
-2
-1.29
-0.21
-0.08
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
1.28
0.58
1.9
1.43
0.01
0.02
0.02
0
0
0.02
0.02
Expenses
1.86
1.71
4.34
3.62
0.92
0.43
1.01
0.25
0.26
8.73
8.77
Operating Profit
-0.58
-1.13
-2.44
-2.19
-0.91
-0.41
-0.99
-0.25
-0.26
-8.71
-8.75
OPM %
-45.31%
-194.83%
-128.42%
-153.15%
-9100%
-2050%
-4950%
—
—
-43550%
-43750%
Other Income
0.01
0.03
0.11
0.16
0.15
1.91
0.29
0
0
0.03
0.03
Interest
0
0
0.01
0.01
0
0
0
0
0
0
0
Depreciation
0.01
0.01
0.02
0.02
0.01
0.01
0
0
0
0
0
PBT
-0.58
-1.11
-2.36
-2.06
-0.77
1.49
-0.7
-0.25
-0.26
-8.68
-8.72
Tax %
124.14%
-5.41%
-1.27%
-3.4%
0%
0%
0%
0%
0%
0%
—
Net Profit
-1.31
-1.05
-2.33
-1.98
-0.77
1.49
-0.71
-0.26
-0.28
-8.16
-8.16
EPS (₹)
-1.28
-0.89
-1.69
-1.34
-0.52
1.01
-0.48
-0.18
-0.19
-3.59
-3.58
Div. Payout %
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
10.26
11.76
13.81
14.81
14.81
14.81
14.81
14.81
14.81
22.75
Reserves
-2.39
-0.4
-1.61
-3.03
-3.66
-1.58
-2.29
-2.55
-2.84
-11
Borrowings
6.5
6.81
7.92
8.58
2.34
2.74
2.08
2.2
2.43
1.66
Other Liabilities
4.88
4.73
6.11
7.85
3.09
1.16
0.96
1.09
1.17
0.98
Total Liabilities
19.25
22.9
26.23
28.21
16.58
17.13
15.56
15.55
15.57
14.39
Fixed Assets
0.46
0.36
0.26
0.13
0.02
0.01
0.01
0.01
0
0
CWIP
14.85
16.13
17.77
18.99
3.26
3.26
3.26
3.26
3.26
2
Investments
0.01
0.01
0.01
0.01
4.22
4.8
4.8
4.79
4.76
9.84
Other Assets
3.93
6.4
8.19
9.08
9.08
9.06
7.49
7.49
7.55
2.55
Total Assets
19.25
22.9
26.23
28.21
16.58
17.13
15.56
15.55
15.57
14.39
Figures in ₹ Crores

Cash Flow

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
-0.26
-3.32
-2.96
-1.05
-0.34
-0.4
0.66
-0.13
-0.23
-4.26
Investing
-1.09
-1.19
-1.55
-1.11
-0.23
0
0
0
0
3.26
Financing
1.27
4.83
4.19
2.17
0.55
0.4
-0.67
0.13
0.22
2.63
Net Cash Flow
-0.08
0.32
-0.32
0.01
-0.02
0.01
0
0
0
1.63
Free Cash Flow
-0.26
-4.51
-4.51
-2.16
-0.57
-0.4
0.66
-0.13
-0.23
-1
CFO/OP
45
294
121
48
37
98
-67
52
88
49
Figures in ₹ Crores

Ratios

Particulars Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
932
1,806
425
556
78,110
38,690
38,325
—
—
365
Inventory Days
0
—
—
—
—
0
0
—
—
0
Cash Conversion Cycle
932
1,806
425
556
78,110
38,690
38,325
—
—
365
Working Capital Days
-1,115
-2,259
-788
-1,463
60,590
58,765
46,173
—
—
-29,748
ROCE %
—
-5.44%
-10.11%
-8.45%
-4.07%
10.12%
-4.58%
-1.72%
-1.8%
-62.42%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Samsrita Labs insights

59 extracted metrics + investor summaries across FY09–FY27.

Shareholding Pattern

Public70.27%Others4.30%Promot.25.44%As ofSep 2026

Documents

Frequently Asked Questions about Samsrita Labs

What does Samsrita Labs Ltd do?
Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)
Where is Samsrita Labs Ltd (SAMSRITA) listed?
Samsrita Labs Ltd trades under code 539267 on the BSE.
Which sector does Samsrita Labs Ltd belong to?
Samsrita Labs Ltd is classified under the Healthcare Services sector, in the Healthcare Service Provider industry.
What is the market capitalisation of Samsrita Labs Ltd?
Samsrita Labs Ltd has a market capitalisation of ₹27.28 Cr as of 28 Oct 2026, which places it in the Small Cap band.
What is the 52-week high and low of Samsrita Labs Ltd?
Over the last 52 weeks Samsrita Labs Ltd has traded between ₹10.15 and ₹25.27 as of 28 Oct 2026.
What is the Return on Equity (ROE) of Samsrita Labs Ltd?
Samsrita Labs Ltd reported a return on equity of -73.90%. Its debt-to-equity ratio is 0.14.

Company Information

Incorporated in 1996, Samsarita Labs Ltd is in the business of healthcare services including hospital, diagnostics, Pharma, and Biotechnology (R&D)

Website drhlsl.com
Listed 2015-08-11
Face Value ₹ 10
Shares Outstanding 2,27,31,128

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/539267.md for Samsrita Labs Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our Indian stock market MCP server.

Explore More

More Hospital & Healthcare Services stocks → FII DII DataStock ScreenerNifty 50 HeatmapF&O Ban ListFII and DII flows, month by monthHow Tapetide Scores changed, month by monthStocks mutual funds are buying, month by month